256 related articles for article (PubMed ID: 19095303)
1. How to use clinical vignettes in hematology--a pilot survey in the context of chronic lymphocytic leukemia.
Camps SM; Chevret S; Lévy V
Leuk Res; 2009 Oct; 33(10):1328-34. PubMed ID: 19095303
[TBL] [Abstract][Full Text] [Related]
2. Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Brugiatelli M; Bandini G; Barosi G; Lauria F; Liso V; Marchetti M; Mauro FR; Meloni G; Zinzani PL; Tura S; ; ;
Haematologica; 2006 Dec; 91(12):1662-73. PubMed ID: 17145603
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival among patients with chronic lymphocytic leukemia (CLL) treated in Department of Hematology, Medical University of Lublin.
Sokołowska B; Wasik E; Kniaź M; Brzozowska J; Podhorecka M; Sledzińska M; Domański D
Ann Univ Mariae Curie Sklodowska Med; 2000; 55():103-9. PubMed ID: 11482058
[No Abstract] [Full Text] [Related]
4. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia.
Ghia P; Ferreri AM; Caligaris-Cappio F
Crit Rev Oncol Hematol; 2007 Dec; 64(3):234-46. PubMed ID: 17544290
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphoproliferative disorders.
Montserrat E; Binet JL; Dighiero G; Gale RP; Juliusson G; Keating M; Rai KR
Rev Invest Clin; 1994 Apr; Suppl():52-8. PubMed ID: 7886310
[No Abstract] [Full Text] [Related]
7. Clinical staging and prognostic markers in chronic lymphocytic leukemia.
Rai KR; Wasil T; Iqbal U; Driscoll N; Patel D; Janson D; Mehrotra B
Hematol Oncol Clin North Am; 2004 Aug; 18(4):795-805, vii. PubMed ID: 15325699
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
9. [Chronic lymphocytic leukemia].
Leporrier M
Rev Prat; 2008 Nov; 58(17):1861-7. PubMed ID: 19157199
[TBL] [Abstract][Full Text] [Related]
10. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
11. Current guidelines in defining therapeutic strategies.
Ferrajoli A; Keating MJ
Hematol Oncol Clin North Am; 2004 Aug; 18(4):881-93, ix. PubMed ID: 15325704
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
[TBL] [Abstract][Full Text] [Related]
13. [Progress in the treatment of chronic lymphocytic leukemia].
Pawelski S
Acta Haematol Pol; 1993; 24(1):5-12. PubMed ID: 8488737
[No Abstract] [Full Text] [Related]
14. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
[TBL] [Abstract][Full Text] [Related]
15. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
16. Danish CLL2-Study revisited: FISH on a cohort with a 20-yr follow-up confirms the validity of the hierarchical model of genomic aberrations in chronic lymphocytic leukaemia.
Geisler C; Jurlander J; Bullinger L; Sander S; Brown P; Benner A; Philip P; Döhner H; Stilgenbauer S;
Eur J Haematol; 2009 Aug; 83(2):156-8. PubMed ID: 19302558
[No Abstract] [Full Text] [Related]
17. Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).
Eichhorst B; Hallek M
Best Pract Res Clin Haematol; 2007 Sep; 20(3):469-77. PubMed ID: 17707834
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations for the cytogenetic management of chronic lymphocytic leukemia established by the French Group for Cytogenetic Hematology].
Groupe Français de Cytogénétique Hématologique (GFCH)
Pathol Biol (Paris); 2004 Jun; 52(5):254-6. PubMed ID: 15217707
[No Abstract] [Full Text] [Related]
19. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.
Cheson BD; Bennett JM; Rai KR; Grever MR; Kay NE; Schiffer CA; Oken MM; Keating MJ; Boldt DH; Kempin SJ
Am J Hematol; 1988 Nov; 29(3):152-63. PubMed ID: 3189311
[TBL] [Abstract][Full Text] [Related]
20. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
